NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

Micro-array profiling exhibits remarkable intra-individual stability of human platelet micro-RNA.

Author(s): Stratz C, Nührenberg TG, Binder H, Valina CM, Trenk D, Hochholzer W, Neumann FJ, Fiebich BL

Publication: Thromb Haemost, 2012, Vol. 107, Page 634-41

PubMed ID: 22371016 PubMed Review Paper? No

Purpose of Paper

The purpose of this paper was to determine the variability in microRNA (miRNA) expression in platelets over the course of 10 days, and to determine the effects of donor consumption of acetylsalicylic acid (ASA, aspirin) on miRNA profiles.

Conclusion of Paper

All 221 miRNAs found to be expressed in platelets showed relatively stable expression over the 10 days of specimen collection, and none were significantly altered 24 hours after patients received a 500 mg dose of ASA on day 9.

Studies

  1. Study Purpose

    The purpose of this study was to determine the variability in miRNA expression in platelets over the course of 10 days, and to determine the effects of donor consumption of ASA on miRNA profiles. Platelets were prepared by leukocyte depletion of platelet rich plasma after blood was collected into trisodium citrate tubes. Platelet pellets were stored at -80 degrees C until RNA extraction using the miRNeasy Mini Kit, and eluted RNA was stored at -80 degrees C until analysis. Microarray analysis was performed using the Geniom Biochip miRNA homosapiens.

    Summary of Findings:

    All 221 miRNAs found to be expressed in platelets showed relatively stable expression over the 10 days of specimen collection, and none were significantly altered 24 hours after patients received a 500 mg dose of ASA on day 9.

    Biospecimens
    Preservative Types
    • Frozen
    Diagnoses:
    • Normal
    Platform:
    AnalyteTechnology Platform
    RNA RT-PCR
    RNA Automated electrophoresis/Bioanalyzer
    RNA DNA microarray
    Cell count/volume Hematology/ auto analyzer
    Cell count/volume Flow cytometry
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Preaquisition Other drugs 500 mg ASA
    No ASA
    Biospecimen Acquisition Time of biospecimen collection Day 0
    Day 1
    Day 3
    Day 9
    Day 10

You Recently Viewed  

News and Announcements

  • April 24, 2024: Biobanking for Precision Medicine Seminar

  • Most Popular SOPs in March 2024

  • New SOPs Available

  • More...